Skip to main content
. 2014 May 22;2014:356427. doi: 10.1155/2014/356427

Figure 1.

Figure 1

Prostate cancers from the TMA “prostatectomy 2” with different expression levels of CD57. (A) Absent expression (score 0). (B) Weak expression (score 1). (C) Moderate expression (score 2). (D) Strong expression (score 3). Immunohistochemistry with an antibody against CD57; original diameter of the TMA spot: 0.6 mm.